pp. 191A-1144A of this free journal suppl. entitled: AASLD AbstractsBACKGROUND/AIM: Estrogens inhibit stellate cell activation and fibrogenesis. Thus, gender/menopause may influence the degree of fibrosis in patients with nonalcoholic steatohepatitis (NASH). We assessed whether gender/menopause is associated with severity of fibrosis (FIB) in adult patients with NASH after taking account of degrees of hepatocyte ballooning (BAL) and portal inflammation (PORT), two significant histologic features well correlated with FIB. METHODS: We analyzed 550 adult patients enrolled at two clinical sites [referral liver clinic (N=344) and bariatric surgery center (N=206)] who had histologic diagnosis of NASH with no co-existing liver conditions or excess...
Background/Aims. Women after menopause have increased insulin resistance and visceral fat, which may...
In patients with nonalcoholic steatohepatitis (NASH), the prevalence of cirrhosis is higher among wo...
Non-alcoholic fatty liver disease (NAFLD) is a multifactorial condition that affects 25% of the worl...
pp. 191A-1144A of this free journal suppl. entitled: AASLD AbstractsBACKGROUND/AIM: How gender and m...
BACKGROUND & AIMS: The risk of nonalcoholic fatty liver disease (NAFLD) and its progression may diff...
Nonalcoholic fatty liver disease (NAFLD) spans steatosis through nonalcoholic steatohepatis, cirrhos...
INTRODUCTION: Chronic hepatitis C is the main cause of death in patients with end-stage liver disea...
Background & aimsSex and sex hormones can affect responses of patients with nonalcoholic fatty l...
In spite of tremendous research advancements in nonalcoholic fatty liver disease (NAFLD), our unders...
Chronic hepatitis C is the main cause of death in patients with end-stage liver disease. Prognosis d...
Contrasting data exist on the effect of gender and menopause on the susceptibility, development and ...
A novel anti-fibrotic role of Sphingosine 1-Phosphate in liver underlies female specific protection ...
p. 180-185Context: Nonalcoholic Fatty Liver Disease (NAFLD) is common in postmenopausal women. It is...
Metabolic liver disease is often accompanies diseases of various body systems. Non-alcoholic fatty l...
Non-alcoholic fatty liver disease (NAFLD) is one of the most serious liver pathologies, with an esti...
Background/Aims. Women after menopause have increased insulin resistance and visceral fat, which may...
In patients with nonalcoholic steatohepatitis (NASH), the prevalence of cirrhosis is higher among wo...
Non-alcoholic fatty liver disease (NAFLD) is a multifactorial condition that affects 25% of the worl...
pp. 191A-1144A of this free journal suppl. entitled: AASLD AbstractsBACKGROUND/AIM: How gender and m...
BACKGROUND & AIMS: The risk of nonalcoholic fatty liver disease (NAFLD) and its progression may diff...
Nonalcoholic fatty liver disease (NAFLD) spans steatosis through nonalcoholic steatohepatis, cirrhos...
INTRODUCTION: Chronic hepatitis C is the main cause of death in patients with end-stage liver disea...
Background & aimsSex and sex hormones can affect responses of patients with nonalcoholic fatty l...
In spite of tremendous research advancements in nonalcoholic fatty liver disease (NAFLD), our unders...
Chronic hepatitis C is the main cause of death in patients with end-stage liver disease. Prognosis d...
Contrasting data exist on the effect of gender and menopause on the susceptibility, development and ...
A novel anti-fibrotic role of Sphingosine 1-Phosphate in liver underlies female specific protection ...
p. 180-185Context: Nonalcoholic Fatty Liver Disease (NAFLD) is common in postmenopausal women. It is...
Metabolic liver disease is often accompanies diseases of various body systems. Non-alcoholic fatty l...
Non-alcoholic fatty liver disease (NAFLD) is one of the most serious liver pathologies, with an esti...
Background/Aims. Women after menopause have increased insulin resistance and visceral fat, which may...
In patients with nonalcoholic steatohepatitis (NASH), the prevalence of cirrhosis is higher among wo...
Non-alcoholic fatty liver disease (NAFLD) is a multifactorial condition that affects 25% of the worl...